Decrease in Hypothalamic Gamma Adducin in Rat Models of Hypertension

Hypertension

Volumn 43, Issue 2, 2004, Pages 324-328

  Yang, Hong ^a   Reaves, Phyllis Y ^a   Katovich, Michael J ^a   Raizada, Mohan K ^a  

^a UNIVERSITY OF FLORIDA COLLEGE OF MEDICINE   (United States)

Author keywords

Angiotensin; Brain; Hypertension; Hypothalamus

Indexed keywords

ADDUCIN; ANGIOTENSIN; DEOXYCORTICOSTERONE ACETATE; GAMMA ADDUCIN; LOSARTAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; BLOOD PRESSURE MEASUREMENT; BRAIN LEVEL; BRAIN NERVE CELL; CELL LEVEL; CONFERENCE PAPER; CONTROLLED STUDY; CORRELATION ANALYSIS; CULTURE MEDIUM; HYPERTENSION; HYPOTHALAMUS; MALE; NERVE CELL CULTURE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; RAT STRAIN; SPONTANEOUSLY HYPERTENSIVE RAT;

ANGIOTENSIN II; ANIMALS; CALMODULIN-BINDING PROTEINS; CELLS, CULTURED; HYPERTENSION; HYPOTHALAMUS; MALE; NEURONS; RATS; RATS, INBRED WKY; RATS, SPRAGUE-DAWLEY;

EID: 0842311505     PISSN: 0194911X     EISSN: 15244563     Source Type: Journal    
DOI: 10.1161/01.HYP.0000113045.12850.cd     Document Type: Article

References (28)

1. Izzo JL Jr., Taylor AA. The sympathetic nervous system and baroreflexes in hypertension and hypotension. Curr Hypertens Rep. 1999; 1: 254-263.
2. Veerasingham SJ, Raizada MK. Brain renin-angiotensin system dysfunction in hypertension: recent advances and perspectives. Br J Pharmacol. 2003; 139: 191-202.
3. Wyss JM, Carlson SH. The role of the nervous system in hypertension. Curr Hypertens Rep. 2001; 3: 255-262.
4. Mancia G, Grassi G, Parati G, Zanchetti A. The sympathetic nervous system in human hypertension. Rev Port Cardiol. 2000; 19: II15-II19.
5. Veerasingham SJ, Sellers K, Raizada MK. Functional genomics as an emerging strategy for central mechanisms in experimental hypertension. Prog Biophys Mol Biol. 2004; in press.
6. Yang H, Francis SC, Sellers K, DeBarros M, Sun C, Sumners C, Ferrario CM, Katovich MJ, Muro AF, Raizada MK. Hypertension-linked decrease in the expression of brain gamma-adducin. Circ Res. 2002; 91: 633-639.
7. Matsuoka Y, Li X, Bennett V. Adducin: structure, function and regulation. Cell Mol Life Sci. 2000; 57: 884-895.
8. Ferrari P, Ferrandi M, Torielli L, Tripodi G, Bianchi G. PST 2238: a new antihypertensive compound that modulates the Na-K pump in vivo and in vitro. Hypertens Res. 2000; 23: S15-S19.
9. Ferrari P, Ferrandi M, Torielli L, Barassi P, Tripodi G, Minotti E, Molinari I, Melloni P, Bianchi G. Antihypertensive compounds that modulate the Na-K pump. Ann N Y Acad Sci. 2003; 986: 694-701.
10. Manunta P, Barlassina C, Bianchi G. Adducin in essential hypertension. FEBS Lett. 1998; 430: 41-44.
11. Sugimoto K, Hozawa A, Katsuya T, Matsubara M, Ohkubo T, Tsuji I, Motone M, Higaki J, Hisamachi S, Imai Y, Ogihara T. alpha-Adducin Gly460Trp polymorphism is associated with low renin hypertension in younger subjects in the Ohasama study. J Hypertens. 2002; 20: 1779-1784.
12. Wang JG, Staessen JA, Barlassina C, Fagard R, Kuznetsova T, Struijker-Boudier HA, Zagato L, Citterio L, Messaggio E, Bianchi G. Association between hypertension and variation in the alpha- and beta-adducin genes in a white population. Kidney Int. 2002; 62: 2152-2159.
13. Pinto YM, Paul M, Ganten D. Lessons from rat models of hypertension: from Goldblatt to genetic engineering. Cardiovasc Res. 1998; 39: 77-88.
14. Johnson ML, Ely DL and Turner ME. Genetic divergence between WKY and SH rats. Hypertension. 1992; 19: 425-427.
15. Pachori AS, Wang H, Gelband CH, Ferrario CM, Katovich MJ, Raizada MK. Inability to induce hypertension in normotensive rat expressing AT(1) receptor antisense. Circ Res. 2000; 86: 1167-1172.
16. Lu D, Raizada MK, Iyer S, Reaves P, Yang H, Katovich MJ. Losartan versus gene therapy: chronic control of high blood pressure in spontaneously hypertensive rats. Hypertension. 1997; 30: 363-370.
17. Baylis C, Qiu C, Engels K. Comparison of L-type and mixed L- and T-type calcium channel blockers on kidney injury caused by deoxycorticosterone-salt hypertension in rats. Am J Kidney Dis. 2001; 38: 1292-1297.
18. Bianciotti LG, de Bold AJ. Natriuretic peptide gene expression in DOCA-salt hypertension after blockade of type B endothelin receptor. Am J Physiol Heart Circ Physiol. 2002; 282: H1127-H1134.
19. Raizada MK, Lu D, Sumners C. AT1 receptors and angiotensin actions in the brain and neuronal cultures of normotensive and hypertensive rats. Adv Exp Med Biol. 1995; 377: 331-348.
20. Yang H, Raizada MK. Role of phosphatidylinositol 3-kinase in angiotensin II regulation of norepinephrine neuromodulation in brain neurons of the spontaneously hypertensive rat. J Neurosci. 1999; 19: 2413-2423.
21. Muro AF, Marro ML, Gajovic S, Porro F, Luzzatto L, Baralle FE. Mild spherocytic hereditary elliptocytosis and altered levels of alpha- and gamma-adducins in beta-adducin-deficient mice. Blood. 2000; 95: 3978-3985.
22. Marro ML, Scremin OU, Jordan MC, Huynh L, Porro F, Roos KP, Gajovic S, Baralle FE, Muro AF. Hypertension in beta-adducin-deficient mice. Hypertension. 2000; 36: 449-453.
23. Fitts DA, Starbuck EM, Ruhf A. Circumventricular organs and ANG II-induced salt appetite: blood pressure and connectivity. Am J Physiol Regul Integr Comp Physiol. 2000; 279: R2277-R2286.
24. Lohmeier TE, Lohmeier JR, Warren S, May PJ, Cunningham JT. Sustained activation of the central baroreceptor pathway in angiotensin hypertension. Hypertension. 2002; 39: 550-556.
25. Gutkind JS, Kurihara M, Saavedra JM. Increased angiotensin II receptors in brain nuclei of DOCA-salt hypertensive rats. Am J Physiol. 1998; 255: H646-H650.
26. Park CG, Leenen FH. Effects of centrally administered losartan on deoxycorticosterone-salt hypertension rats. J Korean Med Sci. 2001; 16: 553-557.
27. Davisson RL. Physiological genomic analysis of the brain renin-angiotensin system. Am J Physiol Regul Integr Comp Physiol. 2003. 285: R498-R511.
28. Yang H, Wang X, Sumners C, Raizada MK. Obligatory role of protein kinase Cbeta and MARCKS in vesicular trafficking in living neurons. Hypertension. 2002; 39: 567-572.